Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 22948175)

1.

Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target.

Zhang F, Rothermund K, Gangadharan SB, Pommier Y, Prochownik EV, Lazo JS.

Oncotarget. 2012 Sep;3(9):998-1010.

2.

Identification of novel drugs to target dormant micrometastases.

Hurst RE, Hauser PJ, You Y, Bailey-Downs LC, Bastian A, Matthews SM, Thorpe J, Earle C, Bourguignon LY, Ihnat MA.

BMC Cancer. 2015 May 14;15:404. doi: 10.1186/s12885-015-1409-4.

3.

Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Peleg R, Romzova M, Kogan-Zviagin I, Apte RN, Priel E.

BMC Cancer. 2014 Dec 3;14:910. doi: 10.1186/1471-2407-14-910.

4.

An in silico screen links gene expression signatures to drug response in glioblastoma stem cells.

Riddick G, Song H, Holbeck SL, Kopp W, Walling J, Ahn S, Zhang W, Fine HA.

Pharmacogenomics J. 2014 Dec 2. doi: 10.1038/tpj.2014.61. [Epub ahead of print]

PMID:
25446780
5.

A strategic approach to identification of selective inhibitors of cancer stem cells.

Patel N, Baranwal S, Patel BB.

Methods Mol Biol. 2015;1229:529-41. doi: 10.1007/978-1-4939-1714-3_41.

PMID:
25325978
6.

A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.

Suntharalingam K, Lin W, Johnstone TC, Bruno PM, Zheng YR, Hemann MT, Lippard SJ.

J Am Chem Soc. 2014 Oct 15;136(41):14413-6. doi: 10.1021/ja508808v. Epub 2014 Oct 6.

PMID:
25247635
7.

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.

Corominas-Faja B, Cuyàs E, Gumuzio J, Bosch-Barrera J, Leis O, Martin ÁG, Menendez JA.

Oncotarget. 2014 Sep 30;5(18):8306-16.

8.

Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells.

Tsuchiya M, Nakajima Y, Hirata N, Morishita T, Kishimoto H, Kanda Y, Kimura K.

Biochem Biophys Res Commun. 2014 Oct 3;452(4):928-32. doi: 10.1016/j.bbrc.2014.09.011. Epub 2014 Sep 16.

PMID:
25234599
9.

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.

Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A.

Oncotarget. 2014 Sep 30;5(18):8665-80.

10.

Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors.

Zhang B, Shimada Y, Kuroyanagi J, Nishimura Y, Umemoto N, Nomoto T, Shintou T, Miyazaki T, Tanaka T.

Tumour Biol. 2014 Dec;35(12):11861-9. doi: 10.1007/s13277-014-2417-8. Epub 2014 Sep 11.

PMID:
25209178
11.
12.

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo.

Klevebring D, Rosin G, Ma R, Lindberg J, Czene K, Kere J, Fredriksson I, Bergh J, Hartman J.

Breast Cancer Res. 2014 Jul 6;16(4):R72. doi: 10.1186/bcr3687.

13.

Synthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells.

Patel NJ, Karuturi R, Al-Horani RA, Baranwal S, Patel J, Desai UR, Patel BB.

ACS Chem Biol. 2014 Aug 15;9(8):1826-33. doi: 10.1021/cb500402f. Epub 2014 Jun 26.

14.

The gender of cell lines matters when screening for novel anti-cancer drugs.

Nunes LM, Robles-Escajeda E, Santiago-Vazquez Y, Ortega NM, Lema C, Muro A, Almodovar G, Das U, Das S, Dimmock JR, Aguilera RJ, Varela-Ramirez A.

AAPS J. 2014 Jul;16(4):872-4. doi: 10.1208/s12248-014-9617-4. Epub 2014 May 30.

15.

Chemical approaches to targeting drug resistance in cancer stem cells.

Sotiropoulou PA, Christodoulou MS, Silvani A, Herold-Mende C, Passarella D.

Drug Discov Today. 2014 Oct;19(10):1547-62. doi: 10.1016/j.drudis.2014.05.002. Epub 2014 May 10. Review.

PMID:
24819719
16.

A multi-phenotypic cancer model with cell plasticity.

Zhou D, Wang Y, Wu B.

J Theor Biol. 2014 Sep 21;357:35-45. doi: 10.1016/j.jtbi.2014.04.039. Epub 2014 May 9.

PMID:
24819463
17.

Biotherapeutic approaches to target cancer stem cells.

Duggal R, Minev B, Geissinger U, Wang H, Chen NG, Koka PS, Szalay AA.

J Stem Cells. 2013;8(3-4):135-49. doi: jsc.2014.8.3/4.135. Review.

PMID:
24699023
18.

Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.

Sun T, Wang Y, Wang Y, Xu J, Zhao X, Vangveravong S, Mach RH, Xia Y.

Adv Healthc Mater. 2014 Aug;3(8):1283-91. doi: 10.1002/adhm.201400026. Epub 2014 Mar 26.

PMID:
24677807
19.

Strategic siRNA screening approaches to target cancer at the Cancer Research UK Beatson Institute.

Shanks EJ.

Comb Chem High Throughput Screen. 2014 May;17(4):328-32.

PMID:
24661213
20.

Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia.

Xu Y, Wang J, Li X, Liu Y, Dai L, Wu X, Chen C.

Biomaterials. 2014 May;35(16):4667-77. doi: 10.1016/j.biomaterials.2014.02.035. Epub 2014 Mar 12.

PMID:
24630839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk